RUNX3-dependent oxidative epithelial-to-mesenchymal transition in methamphetamine-induced chronic lung injury

Lin Shi1, Bing-Yang Liu2, Xin Wang1

  • 1Department of Clinical Pharmacology, School of Pharmacy, China Medical University, No.77 Puhe Road, Shenyang North New Area, Shenyang, 110122, Liaoning, People's Republic of China.

Insights

Methamphetamine (MA) lung injury involves oxidative epithelial-to-mesenchymal transition (EMT). RUNX3 is crucial, as its knockdown worsens MA-induced EMT and lung damage by affecting oxidative stress and TGF-β signaling.

Area of Science:

  • Toxicology
  • Pulmonary Medicine
  • Cell Biology

Background:

  • Methamphetamine (MA) abuse is a leading cause of fatal lung toxicity.
  • The precise mechanisms underlying MA-induced lung injury, particularly epithelial-to-mesenchymal transition (EMT), remain poorly understood.

Purpose of the Study:

  • To investigate whether MA induces EMT in lung tissue.
  • To determine the role of RUNX3 in MA-induced oxidative EMT and chronic lung injury.

Main Methods:

  • Rats were exposed to MA chronically; lung tissues were analyzed morphologically and via Western blot.
  • Cultured alveolar epithelial cells were treated with MA, N-acetyl cysteine (NAC), or RUNX3 knockdown, followed by flow cytometry, Western blot, and immunohistochemistry.

Main Results:

  • Chronic MA exposure led to lung structural changes, oxidative stress, and pulmonary EMT.
  • N-acetyl cysteine (NAC) increased RUNX3 expression and mitigated EMT.
  • RUNX3 knockdown exacerbated MA-induced EMT by activating RUNX3-dependent TGF-β signaling and increasing reactive oxygen species (ROS).

Conclusions:

  • RUNX3 plays a critical role in regulating oxidative stress and EMT in MA-induced chronic lung injury.
  • RUNX3 may be a key therapeutic target for mitigating methamphetamine-related lung damage.